Medicine and Health Sciences Commons^™

A Real World Assessment Of The Efficacy And Safety Of Switching From Tdf To Taf In Treatment Experienced Patients With Hiv Infection, Jaclyn O'Connor, Pharmd Candidate, Kaitlin N. Sassa, Pharmd, Jason J. Schafer, Pharmd, Mph, Bcps Aq-Id, Bcidp, Aahivp

College of Pharmacy Posters

Objective

• The primary objective of this study was to determine if patients maintain viral suppression after switching from TDF to TAF
• The secondary objective was to assess changes in renal function and serum cholesterol levels

Patients Living With Hiv Infection Are Less Likely To Receive The Correct Statin Intensity For Cardiovascular Disease Risk Reduction, Jason J. Schafer, Pharmd, Mph, Roshni Emmons, Pharmd, Bcps, Nick V. Hastain, Pharmd, Todd Miano, Pharmd, Phd

College of Pharmacy Posters

• Patients living with HIV (PLWH) are at high risk for atherosclerotic cardiovascular disease (ASCVD)
• Eligible PLWH should receive statins for ASCVD risk reduction according to current guidelines
• Studies suggest that statins are underprescribed in PLWH, but comparisons to uninfected patients and assessments of statin intensity have not occurred

Objective

To determine the influence of HIV infection on appropriate statin prescribing for ASCVD risk reduction

Exploring The Prevalence And Characteristics Associated With Weight Gain And Metabolic Changes In Plwh Who Are Virologically Suppressed On Antiretroviral Therapy And Switch To Integrase Inhibitor Containing Regimens, Matty Zimmerman, Joseph Desimone Jr., Md, Jason J. Schafer, Pharmd, Mph, Bcps-Aq Id, Bcidp, Aahivp

College of Pharmacy Posters

Objectives

• To determine the prevalence, extent and characteristics of weight gain among virologically suppressed PLWH whose ART has been switched to an INSTI-containing regimen
• To examine the presence of metabolic changes in PLWH who have been switched to INSTI-containing ART

Weight Gain In Patients With Hiv Infection Who Are Virologically Suppressed On Antiretroviral Therapy And Switch To Integrase Inhibitor Containing Regimens, Matty Zimmerman, Jason Schafer, Pharmd, Mph, Bcps, Bcidp, Aahivp

College of Pharmacy Posters

Objective

To determine the prevalence and extent of weight gain among virologically suppressed PLWH whose antiretroviral therapy (ART) has been switched to an integrase inhibitor (INSTI) containing regimen.